Because GDF9 and BMP15 are known to be involved in premature ovarian failure and polycystic ovarian syndrome22, 53, 54, 55, targeting CALR and the ER quality control system in follicular development should be considered as a novel avenue for female infertility treatment. This evidence concerns the gene GDF9 and primary ovarian failure.